Otsu, Japan

Shigeki Kurokawa


Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 27(Granted Patents)


Location History:

  • Ohtsu, JP (1980 - 1986)
  • Otsu, JP (1986 - 1987)

Company Filing History:


Years Active: 1980-1987

Loading Chart...
5 patents (USPTO):

Title: Innovative Contributions of Inventor Shigeki Kurokawa

Introduction

Shigeki Kurokawa, a prominent inventor based in Otsu, Japan, has made significant contributions to the field of pharmaceuticals. With five patents to his name, Kurokawa focuses primarily on developing compounds that address diabetic complications. His innovative research is paving the way for new therapeutic agents that could potentially transform treatment options for patients suffering from diabetes.

Latest Patents

Among Kurokawa's latest patents is a breakthrough involving benzofuran derivatives aimed at treating diabetic complications. The patented compound showcases a complex structure that includes variations of hydrogen atoms, benzyl groups, and various alkyl groups. These compounds exhibit powerful aldose reductase inhibiting activity, platelet aggregation inhibiting activity, and have effects on arachidonic acid metabolism, making them highly valuable in the pharmaceutical industry.

Another significant patent involves rhodanines, which are also designed to act as therapeutic agents for diabetic complications. This rhodanine derivative boasts potent platelet aggregation inhibiting activity and aldose reductase inhibiting activity. These features highlight the potential of Kurokawa's compounds as effective therapeutic agents in clinical settings.

Career Highlights

Throughout his career, Shigeki Kurokawa has collaborated with esteemed organizations, including Kaken Pharmaceutical Company, Ltd. and Kakenyaku Kako Kabushiki Kaisha. His work at these companies has allowed him to engage in groundbreaking research and contribute significantly to advancements in diabetes treatments.

Collaborations

Kurokawa has had the privilege to work alongside notable coworkers, such as Motoyuki Yajima and Katsumi Nogimori. These collaborations have fostered a creative environment that encourages innovation and the discovery of new solutions in the realm of medicine.

Conclusion

In conclusion, Shigeki Kurokawa's contributions to the field of pharmaceuticals—especially concerning diabetes—underline the impact of dedicated research and innovation. His ongoing work and multiple patents reflect a commitment to enhancing patient care and advancing therapeutic options in pharmacology. As the landscape of medical treatments evolves, Kurokawa’s inventions will likely play a critical role in shaping the future of diabetes care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…